These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23984603)

  • 1. [Tumor markers used in the diagnosis, monitoring, treatment, and prognosis head and neck cancer].
    Kopczyński P; Flieger R
    Pol Merkur Lekarski; 2013 Jul; 35(205):37-8. PubMed ID: 23984603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers in patients with head-neck carcinomas].
    Walther EK; Dahlmann N; Gorgulla HT
    Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in fine-needle aspiration washout for cervical lymphadenopathy in patients with known malignancy: preliminary study.
    Suh YJ; Kim MJ; Kim J; Yoon JH; Moon HJ; Kim EK
    AJR Am J Roentgenol; 2011 Oct; 197(4):W730-6. PubMed ID: 21940546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular markers of head and neck cancer].
    Temam S; Janot F
    Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers and lymphatic metastasis in head and neck cancer patients.
    Büntzel J; Hornig A; Glatzel M; Micke O; Bruns F; Schäfer U; Fröhlich D
    Anticancer Res; 2005; 25(3A):1539-42. PubMed ID: 16033056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular diagnostic methods in head and neck cancer.
    Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
    Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current trends in diagnosis and treatment head and neck cancer].
    Lacau St Guily JL
    Rev Prat; 2006 Oct; 56(15):1652-7. PubMed ID: 17137249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of tumor markers in the follow up of malignant neoplasms of the head and neck].
    Grandis S; Screm MC; Cartei G
    Acta Otorhinolaryngol Ital; 1989; 9(6):599-604. PubMed ID: 2699147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiogenetic markers to predict neck node metastasis in head and neck cancers.
    Rao VU; Shenoy AM; Karthikeyan B
    J Cancer Res Ther; 2010; 6(2):142-7. PubMed ID: 20622359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
    Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
    Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of immunohistochemistry to the diagnosis of cervicofacial cancers].
    Darrouzet V; Stoll D; Benassayag C; Deminière C
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(2):201-4. PubMed ID: 2781190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for diagnosis and prognosis.
    Partridge M; Gaballah K; Huang X
    Cancer Metastasis Rev; 2005 Jan; 24(1):71-85. PubMed ID: 15785873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stem cell hypothesis in head and neck cancer.
    Graziano A; d'Aquino R; Tirino V; Desiderio V; Rossi A; Pirozzi G
    J Cell Biochem; 2008 Feb; 103(2):408-12. PubMed ID: 17546610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.